Search for other papers by Nelma Veronica Marques in
Google Scholar
PubMed
Search for other papers by Luiz Eduardo Armondi Wildemberg in
Google Scholar
PubMed
Search for other papers by Monica R Gadelha in
Google Scholar
PubMed
≥ 126 mg/dL, glycated haemoglobin (HbA1c) ≥ 6.5% or receiving medication for hyperglycaemia. Nine patients had undergone transsphenoidal surgery before pasireotide treatment. Most patients had been treated with first-generation SRLs and/or cabergoline
Department of Endocrinology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Xiaolei Hu in
Google Scholar
PubMed
Search for other papers by Fengling Chen in
Google Scholar
PubMed
variability and metabolic control ( 1 ), and mainly with insulin resistance/hyperglycaemia ( 6 , 10 , 14 , 15 , 16 ) or hypoglycaemia ( 6 , 7 , 8 , 10 , 17 , 18 ). Therefore, we named this condition exogenous insulin antibody syndrome (EIAS). Recently
Institute of Clinical Medicine, University of Oslo, Oslo, Norway
Department of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Lørenskog, Norway
Search for other papers by Ivar Følling in
Google Scholar
PubMed
Search for other papers by Anna B Wennerstrøm in
Google Scholar
PubMed
Search for other papers by Tor J Eide in
Google Scholar
PubMed
Department of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Lørenskog, Norway
Search for other papers by Hilde Loge Nilsen in
Google Scholar
PubMed
production of insulin and related molecules could cause or contribute to the two kinds of glucose imbalances seen in patients with phaeochromocytoma. First, hyperglycaemia is common, occurring in 21–37% of the patients and is probably caused by the secreted
Laboratory of Endocrinology, Medical Research Center, Shandong Provincial Qianfoshan Hospital, The First Affiliated Hospital of Shandong First Medical University, Ji-nan, China
Search for other papers by Yuan Zhou in
Google Scholar
PubMed
Laboratory of Endocrinology, Medical Research Center, Shandong Provincial Qianfoshan Hospital, The First Affiliated Hospital of Shandong First Medical University, Ji-nan, China
Search for other papers by ShengNan Wang in
Google Scholar
PubMed
Laboratory of Endocrinology, Medical Research Center, Shandong Provincial Qianfoshan Hospital, The First Affiliated Hospital of Shandong First Medical University, Ji-nan, China
Search for other papers by Jing Wu in
Google Scholar
PubMed
Search for other papers by JianJun Dong in
Google Scholar
PubMed
Department of Endocrinology and Metabology, Shandong Provincial Qianfoshan Hospital, Cheeloo College of Medicine, Shandong University, Ji-nan, China
Search for other papers by Lin Liao in
Google Scholar
PubMed
, mild fasting hyperglycaemia named MODY2 ( 9 ). Clinical features of MODY2 include a non-progressive slight increase in glycated hemoglobin (HbA1c), usually between 5.6% and 7.6%, and mildly raised fasting glucose (usually between 5.4–8.3 mmol/L) ( 10
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Punith Kempegowda in
Google Scholar
PubMed
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Eka Melson in
Google Scholar
PubMed
Search for other papers by Agnes Johnson in
Google Scholar
PubMed
Search for other papers by Lucy Wallett in
Google Scholar
PubMed
Search for other papers by Lucretia Thomas in
Google Scholar
PubMed
Search for other papers by Dengyi Zhou in
Google Scholar
PubMed
Search for other papers by Catherine Holmes in
Google Scholar
PubMed
Search for other papers by Agata Juszczak in
Google Scholar
PubMed
Search for other papers by Mohammed Ali Karamat in
Google Scholar
PubMed
Search for other papers by Sandip Ghosh in
Google Scholar
PubMed
Search for other papers by Wasim Hanif in
Google Scholar
PubMed
Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
Search for other papers by Parth Narendran in
Google Scholar
PubMed
School of Life and Health Sciences, Aston University, Birmingham, UK
Search for other papers by Srikanth Bellary in
Google Scholar
PubMed
absolute risk of death in the lower age groups was small ( 2 ). Diabetic ketoacidosis (DKA) is an acute complication of diabetes characterised by hyperglycaemia, metabolic acidosis and ketosis ( 3 , 4 ). The management of DKA includes aggressive re
University of Belgrade, Medical Faculty, Belgrade, Serbia
Search for other papers by Marko Stojanovic in
Google Scholar
PubMed
Search for other papers by Zida Wu in
Google Scholar
PubMed
Search for other papers by Craig E Stiles in
Google Scholar
PubMed
University of Belgrade, Medical Faculty, Belgrade, Serbia
Search for other papers by Dragana Miljic in
Google Scholar
PubMed
Insitute of Medical Statistics and Informatics, Belgrade, Serbia
Search for other papers by Ivan Soldatovic in
Google Scholar
PubMed
University of Belgrade, Medical Faculty, Belgrade, Serbia
Search for other papers by Sandra Pekic in
Google Scholar
PubMed
University of Belgrade, Medical Faculty, Belgrade, Serbia
Search for other papers by Mirjana Doknic in
Google Scholar
PubMed
University of Belgrade, Medical Faculty, Belgrade, Serbia
Search for other papers by Milan Petakov in
Google Scholar
PubMed
Search for other papers by Vera Popovic in
Google Scholar
PubMed
Search for other papers by Christian Strasburger in
Google Scholar
PubMed
Search for other papers by Márta Korbonits in
Google Scholar
PubMed
ITT) or hyperglycaemia (induced by OGTT). Despite apparent AIP and GH co-localization in somatotroph secretory vesicles upon electromicroscopy and double fluorescence immunostaining ( 3) , results of this study demonstrated that serum AIP
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Pernille H Hellmann in
Google Scholar
PubMed
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Jonatan I Bagger in
Google Scholar
PubMed
Search for other papers by Katrine R Carlander in
Google Scholar
PubMed
Search for other papers by Katrine B Hansen in
Google Scholar
PubMed
Search for other papers by Julie L Forman in
Google Scholar
PubMed
Search for other papers by Joachim Størling in
Google Scholar
PubMed
Search for other papers by Elizaveta Chabanova in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens Holst in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
that expression of 2% of our genome is regulated by glucocorticoids ( 5 ). Prednisolone is known to induce insulin resistance, increased hepatic glucose production, hyperglycaemia and secondary diabetes. Even lean, healthy individuals can experience
Search for other papers by Magnus F G Grøndahl in
Google Scholar
PubMed
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Jonatan I Bagger in
Google Scholar
PubMed
Search for other papers by Malte P Suppli in
Google Scholar
PubMed
Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Gerrit Van Hall in
Google Scholar
PubMed
Search for other papers by Nicolai J W Albrechtsen in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens J Holst in
Google Scholar
PubMed
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Pharmacology, Copenhagen University Hospital – Bispebjerg and Frederiksberg, Copenhagen, Denmark
Copenhagen Center for Translational Research, Copenhagen University Hospital – Bispebjerg and Frederiksberg, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Mikkel B Christensen in
Google Scholar
PubMed
Search for other papers by Asger B Lund in
Google Scholar
PubMed
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
of glucagon, hyperglucagonaemia, are observed in several obesity-related diseases including type 2 diabetes and non-alcoholic fatty liver disease where it contributes to an increased risk of hyperglycaemia ( 3 , 4 , 5 , 6 , 7 , 8 , 9 ). The
Search for other papers by Helga Schultz in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Svend Aage Engelholm in
Google Scholar
PubMed
Search for other papers by Eva Harder in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Ulrik Pedersen-Bjergaard in
Google Scholar
PubMed
Search for other papers by Peter Lommer Kristensen in
Google Scholar
PubMed
plasma glucose level ≥11.1 mmol/L accompanied by classical symptoms of hyperglycaemia). The intensity of plasma glucose measurements is not reported in the paper ( 14 ). The higher incidence of insulin-treated DM in our cohort may be explained by the
Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China
Search for other papers by Lili Liu in
Google Scholar
PubMed
Search for other papers by Zhuo Shao in
Google Scholar
PubMed
Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China
Search for other papers by Ying Xia in
Google Scholar
PubMed
Search for other papers by Jiabi Qin in
Google Scholar
PubMed
Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China
Search for other papers by Yang Xiao in
Google Scholar
PubMed
Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China
Search for other papers by Zhiguang Zhou in
Google Scholar
PubMed
Search for other papers by Zubing Mei in
Google Scholar
PubMed
, the occurrence rate of severe hypoglycaemic events, gastrointestinal side effects from the baseline to the end of treatments and hyperglycaemia with ketosis. Statistical analysis and assessment of study quality and publication bias The pooled